company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1405000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7041000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8446000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8446000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,118000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,118000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8328000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8328000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8328000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8328000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1300000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.64
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1300000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.64
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1254000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.64
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1705000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16679000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18384000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18384000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-115000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-115000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18499000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18499000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18499000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18499000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1300000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-14.32
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1300000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-14.32
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1292000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 12:16:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-14.32
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1714000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11566000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13280000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13280000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-555000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-555000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13835000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13835000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13835000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13835000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1300000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.73
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1300000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.73
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1289000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:37:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.73
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2036000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12440000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14476000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14476000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-405000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-405000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14881000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14908000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14908000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14908000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3900000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,17.27
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3900000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,17.27
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3854000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,17.27
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2425000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16562000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18987000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18987000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18991000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18999000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18999000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18999000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22100000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22100000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22041000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 12:54:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2680000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12840000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15520000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15520000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-172000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-172000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15692000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-35000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15657000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15657000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15657000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25700000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25700000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25744000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 13:59:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2762000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15458000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18220000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18220000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-48000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18268000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18268000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18268000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18268000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25700000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25700000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25906000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 11:29:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2771000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18284000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21055000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21055000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21059000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21059000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21059000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21059000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24900000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24900000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.79
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24915000.0
Clovis Oncology Inc,CLVS,,0001466301,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3218000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12372000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15590000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15590000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-78000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-78000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15668000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15668000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15668000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15668000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26100000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26100000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26034000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3492000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15816000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19308000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19308000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-33000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-33000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19341000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19341000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19341000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19341000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26900000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26900000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26717000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 11:49:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4312000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16063000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20375000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20375000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,55000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20320000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20320000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20320000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20320000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29900000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29900000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30047000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:11:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5545000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22544000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,405000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28494000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28494000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-657000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-657000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29151000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,52000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29203000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29203000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29203000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28700000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.95
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28700000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.95
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28672000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.95
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13625000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13625000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13625000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5320000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32557000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3409000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,822000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42108000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28483000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-106000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-106000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28589000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2129000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30718000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30718000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30718000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33800000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33820000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5265000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28840000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,861000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34966000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34966000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,270000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,270000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34696000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,68000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34764000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34764000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34764000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.03
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33800000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.03
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33872000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 11:39:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.03
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5267000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34965000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,888000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41120000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41120000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,511000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2281000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1770000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39350000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,292000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39642000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39642000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39642000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33900000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.17
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33900000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.17
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33921000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 10:19:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.17
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5605000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50149000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-3409000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1864000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3409000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53890000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-53890000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2093000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,895000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1198000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55088000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-181000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54907000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54907000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54907000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33900000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.61
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33900000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.61
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33889000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.61
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6751000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56750000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,724000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64225000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64225000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2075000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3258000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1183000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-63042000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,102000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63144000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63144000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-63144000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33900000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.86
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33900000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.86
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34011000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.86
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7204000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60368000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,764000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68336000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68336000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2097000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1080000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3177000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71513000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71531000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71531000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-71531000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34100000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.1
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34100000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.1
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34088000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:03:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.1
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8331000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88138000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,783000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,97252000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-97252000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2099000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,78000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2021000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-99273000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-628000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98645000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98645000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-98645000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37700000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.62
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37700000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.62
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37613000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 12:46:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.62
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8238000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,75995000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-26882000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,89557000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,146908000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-146908000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2101000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,900000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1201000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-148109000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-28568000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-119541000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-119541000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-119541000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36000000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.21
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36000000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.21
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36026000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.21
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9827000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74608000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,516000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84951000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-84951000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2104000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-526000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2630000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-87581000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4181000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-83400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-83400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-83400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.17
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.17
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38360000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.17
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9552000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68029000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-25452000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,104517000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,156646000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-156646000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2106000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,379000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1727000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-158373000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-29059000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-129314000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-129314000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-129314000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.37
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.37
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38389000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 12:23:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.37
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9162000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54838000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64000000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64000000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2108000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,186000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1922000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-65922000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-227000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65695000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65695000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65695000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38600000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.7
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38600000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.7
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38538000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:34:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.7
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,78000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,78000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12190000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54954000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67144000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-67136000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2173000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2159000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-69295000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1433000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-70728000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-70728000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-70728000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38500000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.83
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38500000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.83
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38478000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.83
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18523000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18523000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,372000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,372000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18151000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39274000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43543000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4006000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,86823000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68672000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2635000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6647000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9282000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-77954000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-260000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-77694000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-77694000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-77694000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50500000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.54
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50500000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.54
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50602000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.54
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23757000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23757000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,709000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,709000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23048000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44864000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52707000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4490000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,102061000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-79013000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3581000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18629000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22210000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-101223000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-33000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-101190000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-101190000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-101190000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52200000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.94
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52200000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.94
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52223000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,2019-08-02 12:09:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.94
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22757000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22757000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,771000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,771000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21986000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42495000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,63887000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4766000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111148000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-89162000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3376000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2687000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-689000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-89851000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89864000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89864000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-89864000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52600000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.71
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52600000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.71
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52669000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 14:28:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.71
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30351000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30351000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20222000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20222000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10129000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49148000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,71210000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-13262000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107096000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-96967000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3591000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2185000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1406000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-98373000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,888000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-99261000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-99261000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-99261000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52100000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.88
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52100000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.88
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52066000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.88
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33118000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33118000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1120000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1120000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31998000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47761000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62031000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7405000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,117197000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-85199000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3590000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2208000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1382000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-86581000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-160000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86421000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86421000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-86421000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53000000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.63
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53000000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.63
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52891000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.63
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32978000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32978000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1217000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1217000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31761000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48029000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,70746000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6445000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,125220000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-93459000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3817000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23327000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27144000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-120603000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-176000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-120427000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-120427000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-120427000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53100000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.27
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53100000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.27
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53028000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,2019-08-02 12:09:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.27
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37603000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37603000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1212000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1212000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36391000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47350000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,87336000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8134000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,142820000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-106429000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-13202000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1198000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12004000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-94425000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-350000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-94075000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-94075000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-94075000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54700000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.72
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54700000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.72
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54707000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 14:28:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.72
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39307000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39307000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31137000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31137000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8170000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49340000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,72473000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-21984000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,99829000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-91659000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6720000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1362000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5358000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-97017000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2484000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-99501000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-99501000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-99501000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53900000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.81
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53900000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.81
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53873000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.81
